TUR-3 EMULSION FOR INJECTION FOR TURKEYS
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
06-05-2024
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
PARAMYXOVIRUS TYPE 3 INACTIVATED, NEWCASTLE DISEASE VIRUS, ULSTER 2C STRAIN INACTIVATED, TURKEY RHINOTRACHEITIS VIRUS
थमां उपलब्ध:
Merial Animal Health Limited
ए.टी.सी कोड:
QI01CA02
INN (इंटरनेशनल नाम):
PARAMYXOVIRUS TYPE 3 INACTIVATED, NEWCASTLE DISEASE VIRUS, ULSTER 2C STRAIN INACTIVATED, TURKEY RHINOTRACHEITIS VIRUS
डोज़:
Unknown
फार्मास्यूटिकल फॉर्म:
Emulsion for Injection
प्रिस्क्रिप्शन प्रकार:
POM
चिकित्सीय समूह:
Fowl - Turkey
चिकित्सीय क्षेत्र:
Turkey paramyxovirus vaccine + Turkey rhinotracheitis virus vaccine
चिकित्सीय संकेत:
Immunological - Inactivated vaccine
प्राधिकरण का दर्जा:
Authorised
प्राधिकरण की तारीख:
2006-12-21
उत्पाद विशेषताएं
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
TUR-3 emulsion for injection for turkeys.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Emulsion for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Turkeys intended for breeding.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of future breeder turkeys:
- as booster vaccination after priming with live vaccines against Newcastle Disease and Turkey Rhinotracheitis to
reduce mortality and clinical signs of Newcastle Disease and to induce a specific seroconversion against Newcastle
Disease and Turkey Rhinotracheitis in vaccinated birds throughout the laying period
- as vaccination against paramyxovirus type 3 to reduce the decrease in egg production, as demonstrated by challenge
at peak of lay, and to induce a specific seroconversion against paramyxovirus type 3 throughout the laying period.
Onset of immunity: 4 weeks after the first dose of the vaccination schedule. The second dose is required to achieve
protection for the specified duration of immunity.
Duration of immunity: one laying period (demonstrated by serology).
Each dose of vaccine contains:
ACTIVE SUBSTANCES:
Paramyxovirus 3, inactivated strain PMV3, at least
40 HI.U
Newcastle Disease virus, inactivated strain Ulster 2C, at least
50 PD50
Turkey rhinotracheitis virus, inactivated, strain VCO3, at least
9 ELISA.U
ADJUVANT:
Paraffin oil
170 to186 mg
Ester of fatty acids and polyols
6 to 15 mg
For a full list of excipients, see section 6.1.
1 HIU: q.s. to obtain a mean haemagglutination inhibiting antibody titre of 1 in the vaccinated animal
PD50: Minimum protective dose in accordance with Ph.Eur. 870.
1 ELISA U.: q.s. to obtain a positive serum by ELISA in the vaccinated bird
IRISH MEDICINES BOAR
पूरा दस्तावेज़ पढ़ें
